Can shorter dialysis sessions still clean the blood effectively?

NCT ID NCT07348536

Not yet recruiting Knowledge-focused Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether shorter or standard-length dialysis sessions using expanded hemodialysis can remove waste products from the blood as well as a more intensive technique called high-volume hemodiafiltration. Fifteen adults with end-stage kidney disease will try three different session lengths (180, 210, and 240 minutes) and one session of the comparison method. Blood samples will measure how well each session removes toxins.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Expanded hemodialysis with medium cut-off membrane and high-volume online hemodiafiltration
What this could lead to: If successful, this study could help doctors personalize dialysis prescriptions by identifying the shortest effective treatment time for removing toxins.
What could go wrong: This is a very small, early-stage study with only 15 participants, so results may not apply to all dialysis patients. It measures toxin removal, not long-term health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE ON HEMODIALYSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Bronchiolitis Obliterans Syndrome chronic kidney disease end stage renal failure uremia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC KIDNEY DISEASE ON HEMODIALYSIS END STAGE RENAL DISEASE (ESRD) HEMODIAFILTRATION HEMODIALYSIS RENAL DIALYSIS UREMIA; CHRONIC

Contacts and locations

Locations

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran

Mexico City, Mexico City, 14080, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.